文献速递呼吸危重症与机械通气

头盔压力支持、持续气道正压与经鼻高流量氧疗在低氧性呼吸衰竭中的各自效应:随机交叉临床试验

Respective Effects of Helmet Pressure Support, Continuous Positive Airway Pressure, and Nasal High-Flow in Hypoxemic Respiratory Failure: A Randomized Crossover Clinical Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

该随机交叉试验纳入15例PaO2/FiO2≤200的低氧患者,比较头盔NIV、头盔CPAP与HFNO各1小时的效果。头盔NIV较CPAP和HFNO降低吸气努力,NIV与CPAP均较HFNO改善氧合、增加潮气量和呼气末肺容积,NIV减轻pendelluft更明显。

要点

  • 头盔NIV较CPAP和HFNO降低吸气食管压摆动,减轻吸气努力
  • NIV与CPAP均较HFNO提高PaO2/FiO2、潮气量和呼气末肺容积
  • NIV较CPAP更明显减轻pendelluft,跨肺压摆动无统计学差异

核心结论

  • 与HFNO相比,头盔NIV降低ΔPES,而CPAP未降低ΔPES。
  • CPAP与NIV均较HFNO提高氧合、呼气末肺容积和潮气量,且不改变ΔPL。
  • NIV减轻pendelluft,CPAP减轻程度较小。

研究设计与样本

  • 随机交叉临床试验,15例低氧血症患者(PaO2/FiO2≤200)。
  • 每例依次接受1小时HFNO(60 L/min)、头盔NIV(PEEP=14 cm H2O,压力支持=12 cm H2O)和CPAP(PEEP=14 cm H2O),顺序随机,FiO2恒定。
  • 以吸气食管压摆动(ΔPES)和跨肺压摆动(ΔPL)分别作为吸气努力和肺膨胀的替代指标。
  • 用电阻抗断层成像评估潮气量和呼气末肺容积。
  • 临床试验注册号NCT04241861。

主要发现

  • ΔPES在NIV低于CPAP和HFNO:中位数[四分位距]为5[3-9] cm H2O vs. 13[10-19] cm H2O vs. 10[8-13] cm H2O(P=0.001和P=0.01)。
  • ΔPL在各治疗间无统计学差异。
  • PaO2/FiO2在NIV和CPAP高于HFNO:166[136-215]和175[158-281] vs. 120[107-149](P=0.002和P=0.001)。
  • NIV和CPAP较HFNO增加潮气量(平均变化70%[95%CI 17-122%],P=0.02;93%[95%CI 30-155%],P=0.002)和呼气末肺容积(平均变化198%[95%CI 67-330%],P=0.001;263%[95%CI 121-407%],P=0.001),主要因背侧肺区通气/充气增加。
  • HFNO期间15例中14例存在pendelluft且涉及>10%潮气量,CPAP减轻、NIV进一步减轻pendelluft。

临床怎么用

  • 对PaO2/FiO2≤200的低氧患者,头盔NIV在降低吸气努力方面优于CPAP和HFNO。
  • 头盔CPAP与NIV均可改善氧合和肺容积,选择需结合患者耐受性与吸气努力情况。
  • NIV与CPAP可能减轻pendelluft,但需结合个体化评估。

局限性

  • 样本量仅15例,各干预仅1小时,属生理学替代终点研究。
  • 采用ΔPES和ΔPL作为吸气努力与肺膨胀的替代指标。
  • 为随机交叉设计,结果需在更大样本和临床结局研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The respective effects of positive end-expiratory pressure (PEEP) and pressure support delivered through the helmet interface in patients with hypoxemia need to be better understood. Objectives: To assess the respective effects of helmet pressure support (noninvasive ventilation [NIV]) and continuous positive airway pressure (CPAP) compared with high-flow nasal oxygen (HFNO) on effort to breathe, lung inflation, and gas exchange in patients with hypoxemia (PaO2/FiO2 ⩽ 200). Methods: Fifteen patients underwent 1-hour phases (constant FiO2) of HFNO (60 L/min), helmet NIV (PEEP = 14 cm H2O, pressure support = 12 cm H2O), and CPAP (PEEP = 14 cm H2O) in randomized sequence. Measurements and Main Results: Inspiratory esophageal (ΔPES) and transpulmonary pressure (ΔPL) swings were used as surrogates for inspiratory effort and lung distension, respectively. Tidal Volume (Vt) and end-expiratory lung volume were assessed with electrical impedance tomography. ΔPES was lower during NIV versus CPAP and HFNO (median [interquartile range], 5 [3-9] cm H2O vs. 13 [10-19] cm H2O vs. 10 [8-13] cm H2O; P = 0.001 and P = 0.01). ΔPL was not statistically different between treatments. PaO2/FiO2 ratio was significantly higher during NIV and CPAP versus HFNO (166 [136-215] and 175 [158-281] vs. 120 [107-149]; P = 0.002 and P = 0.001). NIV and CPAP similarly increased Vt versus HFNO (mean change, 70% [95% confidence interval (CI), 17-122%], P = 0.02; 93% [95% CI, 30-155%], P = 0.002) and end-expiratory lung volume (mean change, 198% [95% CI, 67-330%], P = 0.001; 263% [95% CI, 121-407%], P = 0.001), mostly due to increased aeration/ventilation in dorsal lung regions. During HFNO, 14 of 15 patients had pendelluft involving >10% of Vt; pendelluft was mitigated by CPAP and further by NIV. Conclusions: Compared with HFNO, helmet NIV, but not CPAP, reduced ΔPES. CPAP and NIV similarly increased oxygenation, end-expiratory lung volume, and Vt, without affecting ΔPL. NIV, and to a lesser extent CPAP, mitigated pendelluft. Clinical trial registered with clinicaltrials.gov (NCT04241861).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Menga LS, Delle Cese L, Rosà T, et al. Respective Effects of Helmet Pressure Support, Continuous Positive Airway Pressure, and Nasal High-Flow in Hypoxemic Respiratory Failure: A Randomized Crossover Clinical Trial. Am J Respir Crit Care Med. 2023. PMID: 36378814. doi:10.1164/rccm.202204-0629OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。